OTTAWA—Health Minister Jean-Yves Duclos has put a six-month pause on new regulations designed to lower the cost of patented medicines in Canada.
Health Canada first announced the changes in 2019 to protect Canadians from excessive drug prices, but the government has repeatedly delayed implementing the rules.